319 related articles for article (PubMed ID: 23329007)
1. Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder.
Segebladh B; Bannbers E; Moby L; Nyberg S; Bixo M; Bäckström T; Sundström Poromaa I
Arch Womens Ment Health; 2013 Apr; 16(2):131-7. PubMed ID: 23329007
[TBL] [Abstract][Full Text] [Related]
2. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
[TBL] [Abstract][Full Text] [Related]
3. Stress, mood, and cortisol during daily life in women with Premenstrual Dysphoric Disorder (PMDD).
Beddig T; Reinhard I; Kuehner C
Psychoneuroendocrinology; 2019 Nov; 109():104372. PubMed ID: 31357135
[TBL] [Abstract][Full Text] [Related]
4. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-adrenal function in patients with the premenstrual syndrome.
Rabin DS; Schmidt PJ; Campbell G; Gold PW; Jensvold M; Rubinow DR; Chrousos GP
J Clin Endocrinol Metab; 1990 Nov; 71(5):1158-62. PubMed ID: 2172272
[TBL] [Abstract][Full Text] [Related]
6. Allopregnanolone has no effect on startle response and prepulse inhibition of startle response in patients with premenstrual dysphoric disorder or healthy controls.
Kask K; Bäckström T; Lundgren P; Sundström Poromaa I
Pharmacol Biochem Behav; 2009 Jun; 92(4):608-13. PubMed ID: 19268499
[TBL] [Abstract][Full Text] [Related]
7. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
[TBL] [Abstract][Full Text] [Related]
8. Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.
Bixo M; Johansson M; Timby E; Michalski L; Bäckström T
J Neuroendocrinol; 2018 Feb; 30(2):. PubMed ID: 29072794
[TBL] [Abstract][Full Text] [Related]
9. Historical sexual abuse and current thyroid axis profiles in women with premenstrual dysphoric disorder.
Girdler SS; Thompson KS; Light KC; Leserman J; Pedersen CA; Prange AJ
Psychosom Med; 2004; 66(3):403-10. PubMed ID: 15184704
[TBL] [Abstract][Full Text] [Related]
10. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
[TBL] [Abstract][Full Text] [Related]
11. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic amenorrhea with normal body weight: ACTH, allopregnanolone and cortisol responses to corticotropin-releasing hormone test.
Meczekalski B; Tonetti A; Monteleone P; Bernardi F; Luisi S; Stomati M; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 Mar; 142(3):280-5. PubMed ID: 10700723
[TBL] [Abstract][Full Text] [Related]
13. Cortisol circadian rhythms during the menstrual cycle and with sleep deprivation in premenstrual dysphoric disorder and normal control subjects.
Parry BL; Javeed S; Laughlin GA; Hauger R; Clopton P
Biol Psychiatry; 2000 Nov; 48(9):920-31. PubMed ID: 11074230
[TBL] [Abstract][Full Text] [Related]
14. ACTH and cortisol response to Dex/CRH testing in women with and without premenstrual dysphoria during GnRH agonist-induced hypogonadism and ovarian steroid replacement.
Lee EE; Nieman LK; Martinez PE; Harsh VL; Rubinow DR; Schmidt PJ
J Clin Endocrinol Metab; 2012 Jun; 97(6):1887-96. PubMed ID: 22466349
[TBL] [Abstract][Full Text] [Related]
15. Stress sensitivity in metastatic breast cancer: analysis of hypothalamic-pituitary-adrenal axis function.
Spiegel D; Giese-Davis J; Taylor CB; Kraemer H
Psychoneuroendocrinology; 2006 Nov; 31(10):1231-44. PubMed ID: 17081700
[TBL] [Abstract][Full Text] [Related]
16. Premenstrual syndrome is associated with blunted cortisol reactivity to the TSST.
Huang Y; Zhou R; Wu M; Wang Q; Zhao Y
Stress; 2015; 18(2):160-8. PubMed ID: 25518868
[TBL] [Abstract][Full Text] [Related]
17. Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study.
Timby E; Bäckström T; Nyberg S; Stenlund H; Wihlbäck AN; Bixo M
Psychopharmacology (Berl); 2016 Jun; 233(11):2109-2117. PubMed ID: 26960697
[TBL] [Abstract][Full Text] [Related]
18. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
[TBL] [Abstract][Full Text] [Related]
19. Altered psychobiological responsiveness in women with irritable bowel syndrome.
Suárez-Hitz KA; Otto B; Bidlingmaier M; Schwizer W; Fried M; Ehlert U
Psychosom Med; 2012; 74(2):221-31. PubMed ID: 22286854
[TBL] [Abstract][Full Text] [Related]
20. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.
Lombardi I; Luisi S; Quirici B; Monteleone P; Bernardi F; Liut M; Casarosa E; Palumbo M; Petraglia F; Genazzani AR
Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
